ALLMedicine™ Pancreatitis Center
Research & Reviews 9,922 results
https://doi.org/10.1016/j.gie.2023.01.049
Gastrointestinal Endoscopy; Ashat M, Kandula S et. al.
Feb 5th, 2023 - Post ERCP pancreatitis (PEP) is the most frequent adverse event of endoscopic retrograde cholangiopancreatography (ERCP). Various prophylactic measures are endorsed by ASGE (American Society of Gastrointestinal Endoscopy) and ESGE (European Societ...
https://doi.org/10.1097/XCS.0000000000000609
Journal of the American College of Surgeons; Mustansir F, Jajja MR et. al.
Feb 4th, 2023 - Current Procedural Terminology (CPT) coding allows addition of a two-digit modifier code to denote particularly difficult procedures necessitating additional reimbursement, called the Modifier 22. The use of Modifier 22 in relation to pancreatic s...
https://doi.org/10.1111/jgh.16137
Journal of Gastroenterology and Hepatology; Phan VA, Ruszkiewicz A et. al.
Feb 4th, 2023 - In the absence of rapid on-site evaluation (ROSE), it is not clear which method of tissue preparation is best to process tissue obtained from EUS-guidance. Cytological-smearing (CS), cell-block (CB) and direct-histology (DH) are the available tech...
https://doi.org/10.1053/j.gastro.2023.01.028
Gastroenterology Bourgault J, Abner E et. al.
Feb 4th, 2023 - Acute pancreatitis (AP) is a complex disease and the leading cause of gastro-intestinal disease-related hospital admissions. Few therapeutic options exist for AP prevention. Blood proteins with causal evidence may represent promising drug targets,...
http://emedicine.medscape.com/article/234587-overview
Feb 3rd, 2023 - Practice Essentials Definitions Sepsis is a life-threatening syndrome usually caused by bacterial infection. Sepsis is a response of the body's immune system that results in organ dysfunction or failure. The systemic inflammatory response syndrome...
Guidelines 35 results
https://doi.org/10.1016/j.gie.2022.10.005
Gastrointestinal Endoscopy; Buxbaum JL, Freeman M et. al.
Dec 15th, 2022 - American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations.|2022|Buxbaum JL,Freeman M,Amateau SK,Chalhoub JM,Coelho-Prabhu N,|adverse effects,etiology,prevention & control,
https://doi.org/10.1016/j.gie.2022.09.011
Gastrointestinal Endoscopy; , Buxbaum JL et. al.
Dec 15th, 2022 - American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence.|2022| ,Buxbaum JL,Freeman M,Amateau SK,Chalhoub JM,|adverse effects,methods,etiology,prevention & control,
https://doi.org/10.1053/j.gastro.2022.07.079
Gastroenterology Strand DS, Law RJ et. al.
Aug 26th, 2022 - The purpose of this American Gastroenterological Association (AGA) Clinical Practice Update Expert Review is to provide practical, evidence-based guidance to clinicians regarding the role of endoscopy for recurrent acute and chronic pancreatitis. ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936
Orphanet Journal of Rare Diseases; Mosbah H, Donadille B et. al.
Apr 21st, 2022 - Dunnigan syndrome, or Familial Partial Lipodystrophy type 2 (FPLD2; ORPHA 2348), is a rare autosomal dominant disorder due to pathogenic variants of the LMNA gene. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole N...
https://doi.org/10.1002/jhbp.1146
Journal of Hepato-biliary-pancreatic Sciences; Takada T, Isaji S et. al.
Apr 8th, 2022 - In preparing the Japanese (JPN) guidelines for the management of acute pancreatitis 2021, the committee focused the issues raised by the results of nationwide epidemiological survey in 2016 in Japan. In addition to a systematic search using the pr...
Drugs 644 results see all →
Clinicaltrials.gov 836 results
https://clinicaltrials.gov/ct2/show/NCT01355094
Feb 3rd, 2023 - Excessive pressure within the peritoneal cavity, known as intra-abdominal hypertension (IAH), can adversely affect not only intra-peritoneal organ function, but also other organ systems throughout the body. When IAH > 20 mmHg induces new organ dys...
https://clinicaltrials.gov/ct2/show/NCT05611840
Feb 2nd, 2023 - Background (i) Background information Gallstone disease is a very common disease identity in developed countries, causing a major health burden. There is an estimate of 20 - 25 million adults diagnosed to have gallstone disease annually, resulting...
https://clinicaltrials.gov/ct2/show/NCT02041936
Feb 1st, 2023 - The prognosis for pancreatic cancer is dismal, with a five-year survival rate of 4.9%. Current treatment options include surgical resection, chemotherapy and radiation. Only 15% percent of pancreatic cancers are considered resectable at the time o...
https://clinicaltrials.gov/ct2/show/NCT05252754
Feb 1st, 2023 - Background: In the US alone, almost 700,000 endoscopic retrograde cholangiopancreatographies (ERCPs) are performed each year, and the utilization of ERCP over the last 10 years has increased due to the established therapeutic benefit of the proced...
https://clinicaltrials.gov/ct2/show/NCT04804215
Jan 30th, 2023 - Aim of study Primary end-point To compare and evaluate the incidence of biliary tract complications within 6 months after surgery according to the presence or absence of an intrabiliary stent during biliary reconstruction in liver transplantation....
News 958 results
https://www.mdedge.com/familymedicine/article/260817/pain
MDedge Family Medicine; Faiza Khondoker, DO, Erik Weitz, DO et. al.
Jan 26th, 2023 - THE CASE A 42-year-old man with a history of bipolar disorder with psychotic features, asthma, and chronic pain was brought to the emergency department (ED) by his father due to altered mental status, coughing, and vomiting. The patient was unable.
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/102764
Jan 23rd, 2023 - Use of duodenoscopes with disposable elevator caps during endoscopic retrograde cholangiopancreatography (ERCP) led to lower rates of contamination following high-level disinfection compared with standard scope designs, and did not affect the tech...
https://www.medpagetoday.com/endocrinology/generalendocrinology/101956
Nov 29th, 2022 - "Best" medical treatment with drugs such as SGLT2 inhibitors and GLP-1 receptor agonists was just as effective as Roux-en-Y gastric bypass at achieving albuminuria remission in patients with diabetic kidney disease and class I obesity. (eClinicalM...
https://www.onclive.com/view/fda-approves-additional-intramuscular-dosing-schedule-for-rylaze-in-all-and-lbl
Nov 18th, 2022 - The FDA has approved a supplemental biologics license application to add a Monday/Wednesday/Friday (MWF) intramuscular dosing schedule for asparaginase erwinia chrysanthemi (recombinant)-rywn (Rylaze).1 In June 2021, Rylaze was approved for use a...
https://www.onclive.com/view/ponatinib-provides-higher-rate-of-mrd-negative-cr-vs-imatinib-in-newly-diagnosed-ph-all
Nov 17th, 2022 - Ponatinib (Iclusig) plus reduced-intensity chemotherapy produced a higher rate of minimal residual disease (MRD)–negative complete remission compared with imatinib (Gleevec) in patients with newly diagnosed Philadelphia chromosome (Ph)–positive ac...